Lifecore Biomedical, Inc. ( LFCR) - Key Metrics
LFCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.91 | -$0.16 | -$0.06 | -$0.07 |
| 2026Q3 | $0.62 | -$0.40 | $0.13 | $0.10 |
| 2026Q2 | $0.91 | -$0.16 | $0.01 | -$0.03 |
| 2026Q1 | $0.83 | -$0.27 | $0.05 | $0 |
| 2025Q4 | $0.98 | -$0.03 | $0.14 | $0.09 |
LFCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.91 |
| 2026Q3 | 0% | -2.16 |
| 2026Q2 | 0% | -10.76 |
| 2026Q1 | 0% | -6.34 |
| 2025Q4 | 0% | -30.38 |
LFCR
Price: $6.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.27 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 245.3 million